Why the study?
Does female gender increase the risk of drug-induced long QT syndrome and torsade de pointes compared to male gender?
Does female gender increase the risk of drug-induced long QT syndrome and torsade de pointes compared to male gender?
Women are at a significantly higher risk for drug-induced long QT syndrome and torsade de pointes, highlighting the need for sex-specific considerations when prescribing QT-prolonging medications.
Numerous drugs from diverse classes, such as antiarrhythmics, antihistamines, gastrokinetics, antipsychotics and antibiotics, share the potential to induce a prolongation of the QT interval on the electrocardiogram and torsade de pointes ventricular arrhythmias. The underlying mechanism of these side-effects is the blocking of voltage-gated potassium channels, particularly the rapid component IKr, of the delayed rectifier IK. The risk of such drug-induced arrhythmias is far greater in women than in men. Clinical data as well as experimental studies show that, in comparison to men, the feminine gender is associated with a longer baseline QT interval, a greater response to drugs that block IKr and a greater propensity to drug-induced torsade de pointes. This is most likely the result of a specific regulation of channel expression by — and perhaps a direct non genomic effect of — sex steroids.
No takes yet. Share an insight, caveat, or question.
M.D. Drici (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: